Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NTGN - Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - NTGN FSB OPB


NTGN - Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - NTGN FSB OPB

NEW YORK, NY / ACCESSWIRE / April 7, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders:

Neon Therapeutics, Inc. (NASDAQ:NTGN)

The investigation concerns whether Neon and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Neon to BioNTech SE for 0.063 American Depositary Shares of BioNTech for each share of Neon. If you are a Neon shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/neon-therapeutics-inc-ntgn-stock-merger-biontech/.

Franklin Financial Network, Inc. (NYSE:FSB)

The investigation concerns whether Franklin Financial and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Franklin Financial to FB Financial for 0.9650 shares of FB Financial common stock and $2.00 in cash for each share of Franklin Financial. If you are a Franklin Financial shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/franklin-financial-network-inc-fsb-stock-merger-fb-financial/.

Opus Bank (NASDAQ:OPB)

The investigation concerns whether Opus Bank and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Opus Bank to Pacific Premier Bancorp, Inc. If you are an Opus Bank shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/opus-bank-opb-stock-merger-pacific-premier/.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP



View source version on accesswire.com:
https://www.accesswire.com/584189/Are-Shareholders-Getting-a-Fair-Deal-Halper-Sadeh-LLP-Investigates-the-Sale-of-These-Companies--NTGN-FSB-OPB

Stock Information

Company Name: Neon Therapeutics Inc.
Stock Symbol: NTGN
Market: NASDAQ
Website: neontherapeutics.com

Menu

NTGN NTGN Quote NTGN Short NTGN News NTGN Articles NTGN Message Board
Get NTGN Alerts

News, Short Squeeze, Breakout and More Instantly...